Edition:
United Kingdom

Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)

CRBP.OQ on NASDAQ Stock Exchange Global Market

7.65USD
8:42pm GMT
Change (% chg)

$0.10 (+1.32%)
Prev Close
$7.55
Open
$7.65
Day's High
$7.70
Day's Low
$7.40
Volume
74,279
Avg. Vol
179,109
52-wk High
$10.50
52-wk Low
$5.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.80 -0.139
Jun '17 0.35 -0.145
Mar '17 1.29 -0.161
FY 2016 Dec '16 0.38 -0.171
Sep '16 0.74 -0.122
Jun '16 0.40 -0.108
Mar '16 0.40 -0.077
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.95 2.50 0.00 --
Quarter Ending Jun-18 3 0.95 2.50 0.00 --
Year Ending Dec-18 5 2.28 10.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 3 -0.16 -0.14 -0.19 --
Quarter Ending Jun-18 3 -0.19 -0.17 -0.21 --
Year Ending Dec-18 4 -0.72 -0.69 -0.78 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 134.55 110.72 5.77
Price to Book (MRQ) 9.89 13.56 5.41
Price to Tangible Book (MRQ) 9.89 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 31.38 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -11.70 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago 108.00 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.45 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -89.47 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 6.37 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.10 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -996.89 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -1,001.05 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -1,002.11 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -1,002.11 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 110,485 22,602,130 855,673,508
Net Income/Employee (TTM) -1,107,175 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.08 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -82.39 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -100.08 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -100.21 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 194.80 -- --
EPS (TTM) % -72.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Corbus Pharmaceuticals Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 37.71%
# of Holders: 117
Total Shares Held: 20,966,046
3 Mo. Net Change: 5,934,970
# New Positions: 27
# Closed Positions: 8
# Increased Positions: 72
# Reduced Positions: 28
# Net Buyers: 44
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.